MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
Product Specialist |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 05, 2024 |
(高级)医药代表 /(资深)产品专员 |
Qinnan (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 04, 2024 |
Sales Value Associate CDMX - Privado |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Sales |
Αυγ 01, 2024 |
Key Account Manager |
Bulgaria |
Bulgaria |
International |
Innovative Medicines |
Sales |
Αυγ 01, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shenyang (Liaoning Province) |
China |
International |
Innovative Medicines |
Sales |
Αυγ 01, 2024 |
Sales Value Associate Privado - Guadalajara |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Sales |
Ιουλ 31, 2024 |
Key Account Manager |
Kemerovo |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Ιουλ 31, 2024 |
Commercial Account Manager |
Western Australia (WA) |
Australia |
International |
Innovative Medicines |
Sales |
Ιουλ 31, 2024 |
MR (営業) - 日本全国 |
Tokyo |
Japan |
International |
Innovative Medicines |
Sales |
Ιουλ 31, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior Sales Representative - Ophthalmology |
Mapletree Business City (MBC) |
Singapore |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
County Executive |
Maoming (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Product Specialist |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 30, 2024 |
Business Analyst |
Moscow (City) |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Ιουλ 29, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |
MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Ιουλ 28, 2024 |